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Abstract
Background: During the last years,
19F-MRI and perfluorocarbon nanoemulsion (PFC) emerged as a powerful contrast agent
based MRI methodology to track cells and to visualize inflammation. We applied this new modality to visualize deep tissue
abscesses during acute and chronic phase of inflammation caused by Staphylococcus aureus infection.
Methodology and Principal Findings: In this study, a murine thigh infection model was used to induce abscess formation
and PFC or CLIO (cross linked ironoxides) was administered during acute or chronic phase of inflammation. 24 h after
inoculation, the contrast agent accumulation was imaged at the site of infection by MRI. Measurements revealed a strong
accumulation of PFC at the abscess rim at acute and chronic phase of infection. The pattern was similar to CLIO
accumulation at chronic phase and formed a hollow sphere around the edema area. Histology revealed strong influx of
neutrophils at the site of infection and to a smaller extend macrophages during acute phase and strong influx of
macrophages at chronic phase of inflammation.
Conclusion and Significance: We introduce
19F-MRI in combination with PFC nanoemulsions as a new platform to visualize
abscess formation in a murine thigh infection model of S. aureus. The possibility to track immune cells in vivo by this
modality offers new opportunities to investigate host immune response, the efficacy of antibacterial therapies and the
influence of virulence factors for pathogenesis.
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Introduction
In recent years, several in vivo imaging modalities were
developed to monitor infections in real-time and non-invasively.
Bioluminescent imaging (BLI) enables detection of luminescent
bacteria in several animal models [1,2]. Moreover, Fluorine-18-
deoxyglucose and fluorinated pyrimidine nucleosides have been
applied to visualize sites of inflammation or infection by positron
emission tomography (PET) [3,4]. Another imaging modality is
magnetic resonance imaging (MRI), which has been adapted
especially in combination with contrast agents to image edema and
inflammation. In this context,
1H-based MRI has been proven to be
suitable to detect edema pattern in muscoskeletal [5,6] and
inflammatory lesions in lung infection models [7,8]. However,
inflammatory reactions like accumulation of liquid in the interstitial
space are unspecific and lead to inaccuracy in diagnosis of infection
inpostoperativeandposttraumaticsituations [9].Nonetheless,MRI
is a preferable modality because it is able to provide soft tissue
contrast and higher spatial resolution compared to other imaging
technologies such as BLI or PET. Therefore, the development of a
MRI contrast agent to visualize inflammation and to monitor the
efficacy of therapeutic measures would be of great benefit.
Recently, USPIO (ultrasmall paramagnetic ironoxides) nano-
particles were evaluated as inflammation specific contrast agents
[5]. They are phagocytosed after intravenous administration by
monocytes/macrophages in the bloodstream. The phagocytes
migrate then to the infection site, in turn leading to accumulation
of ironoxide nanoparticles. Since the susceptibility effects of iron
particles results in signal reduction on MR images, a differenti-
ation of inflammatory area, edema pattern and surrounding tissue
becomes visible [5,10]. Previous work with USPIOs during acute
or chronic phase of S. aureus soft tissue infection revealed a signal
reduction at the abscess wall in T2 or T2* weighted MRI [10].
However, since superparamagnetic agents lead to signal extinction
in MR images, the identification of affected areas is sometimes
challenging. Furthermore, USPIOs are not suitable to visualize
tissue changes in organs like the lung, which appear dark on
conventional MR images.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18246Recently, a new class of MRI contrast media appeared:
perfluorocarbon nanoemulsions. They are chemically and biolog-
ically inert synthetic molecules [11]. Importantly, the fluorine-19
nucleus is very useful for MRI due to its favorable gyromagnetic
ratio (signal sensitivity of 89% in comparison to
1H). Furthermore,
the very low biological abundance of
19F recommends its use as a
MRI marker, since administered perfluorocarbon contrast media
deliver unambiguous signals in vivo [12]. In one approach, PFCs
have been used to label cells ex vivo and track their migration after
administration in vivo. The migration of T cells in a murine model
of diabetes [13] or the migration of dendritic cells to lymph nodes
[14] was visualized by this modality. Another approach was the
administration of PFCs into the blood stream, where they are
phagocytosed by the monocyte/macrophage system and to a
lower extend by neutrophils [15,16]. The subsequent accumula-
tion of these phagocytic cells at the site of inflammation after
cardiac, cerebral ischemia [15] or pneumonia [16] could be
visualized by
19F-MRI. However, to the best knowledge of the
authors, PFC nanoemulsions have not been used yet to target,
visualize and monitor infections.
Consequently, the purpose of this study was to evaluate the
capability of PFC nanoemulsions to visualize and monitor
infections. Therefore, we applied a basic animal model of
Staphylococcus aureus infection and imaged the accumulation of
19Fluorine at the site of infection following PFC administration
during acute and chronic phase of infection.
Results
T2 weighted MRI visualized the edema pattern caused by
infection
We recorded T2 maps to visualize the edema pattern caused by
S. aureus infection in the thigh muscle. It was shown previously that
T2 values increase at the site of infection during inflammatory
response [5,6,10]. All imaged mice developed increased T2 values
in the infected left thigh muscle, which were visualized by T2 maps
(Fig. 1A/C, Fig. 2A/C). The edema pattern appeared diffuse in all
imaged mice and defined no clear border to surrounding muscle
tissue. Injection of sterile 0,9% NaCl-solution into the right thigh
muscle did not lead to increased signal intensity in T2 maps. Mice
that received CLIO particles at acute phase of inflammation
showed diffuse arranged ‘dark’ spots of signal decrease at the rim
of the edema area (Fig. 1C). They are induced by signal distortion
effects caused by the ironoxide nanoparticles. The administration
of CLIO nanoparticles at chronic phase of inflammation lead to a
‘dark’ rim of signal distortion around the edema area (Fig. 2C).
PFC accumulates in the shape of a hollow sphere around
the edema area at acute phase
To visualize the accumulation of PFC nanoparticles at the site
of infection,
19F-SSFP CSI images were recorded and overlayed
on
1H-TSE images which were used as anatomical reference. PFC
nanoemulsion was administered intravenously at day 2 post
infection and the mice were imaged 24 h later to analyze the
accumulation of
19F at the site of infection during acute phase of
inflammation. The PFC nanoparticles accumulated in all
investigated mice in the shape of a hollow sphere at the rim of
the edema pattern, which was defined by increased T2 values in
comparison to surrounding muscle tissue (Fig. 3, Fig. 1B). No
accumulation of PFC could be detected in the center of the abscess
or in the right control thigh muscle, which was inoculated with
sterile 0,9% NaCl-solution. Furthermore, no
19F signal was
detected in infected mice without the administration of PFC
nanoparticles (data not shown).
CLIO accumulates diffuse around edema area at acute
phase
We administered CLIO nanoparticles at day 2 post infection
and imaged the mice 24 h later to compare the accumulation of
PFC and ironoxide nanoparticles during acute phase of inflam-
mation. The T2 maps, which were recorded to visualize the edema
area, showed sparse and diffuse susceptibility effects at the rim of
the edema pattern (Fig. 1C). T2* maps showed the signal distortion
caused by accumulation of ironoxide nanoparticles at the edema
rim (Fig. 1D). CLIO particles accumulated in all investigated mice
only sparse and diffuse around the edema area and defined no
clear border of the abscess area. No accumulation of CLIO could
be visualized in the control thigh muscle.
PFC and CLIO accumulate in the shape of a hollow
sphere at chronic phase
To investigate and compare the accumulation of PFC and
CLIO nanoparticles at the abscess area during chronic phase of
inflammation, PFC or CLIO was inoculated intravenously at day
8 post infection and the mice were imaged 24 h later. T2 and T2*
maps of all mice, that received CLIO, revealed strong signal
extinction at the abscess rim of the infected muscle and thus
accumulation of ironoxide nanoparticles (Fig. 2C/D).
19F signal of
all PFC group mice showed strong accumulation at the rim of the
edema area (Fig. 2B) similar to the accumulation pattern of
ironoxide in CLIO group mice. CLIO as well as PFC (Fig. 4)
accumulated in the shape of a hollow sphere at the border, but
never in the center of the edema pattern. Neither PFC nor CLIO
administration lead to a detectable signal in the control muscle.
Thereby, differentiation of edema area and surrounding muscle
tissue becomes possible by the use of CLIO as contrast agent as
well as with PFC.
Time course imaging of PFC accumulation
We administrated PFC into a fifth group of infected animals
48h p.i. to visualize changes in the
19F accumulation pattern over
time (Fig. 5). Imaging led to an equal pattern at d3 p.i. compared
to acute group mice. Further measurements every 48 h demon-
strated stability of
19F signal around the abscess area until the end
point of this experiment (d9 p.i.).
Histological examination of imaged muscles
HE staining of muscles from acute phase groups showed a very
dense infiltrate of neutrophils at the abscess rim with some
interspersed macrophages. They surrounded a central necrotic
area. No difference of immune cell composition or density
between PFC and CLIO group was observable (Fig. 6A/B).
Chronic phase of inflammation was characterized by a bulky
central necrosis encircled by a dense layer of granulocytes,
macrophages and fibroblast-enriched granulation tissue. No
difference in immune cell content or abscess size could be
delineated between PFC and CLIO group mice (Fig. 7A/B).
Iron specific staining revealed cellular deposits of iron primarily
in macrophages, but also in some neutrophils. Comparison of
histological slices derived from acute (Fig. 6C) and chronic
(Fig. 7C) inflammation groups stained with Berlin blue iron
staining revealed stronger accumulation of iron-loaded macro-
phages during chronic phase of inflammation.
Discussion
The aim of this study was to evaluate PFC nanoparticles as a
new class of contrast media to target and visualize sites of bacterial
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aureus due to its localized and bulky abscess formation. It was
shown before, that this animal model mirrors acute and chronic
phase of inflammation during course of infection [10]. The acute
phase of inflammation was thereby characterized by strong
immigration of neutrophils to the infection site and influx of
liquid and plasma components into the interstitial space [10]. Our
results are consistent with previous studies which observed that the
emerging edema pattern led to increased T2 values at the site of
inflammation. However, one major limitation of edema visualiza-
tion by T2 weighted MRI is that no sharp edges to localize exactly
the area of infection can be defined. Therefore, a method to target
pro-inflammatory immune cells, such as macrophages and
neutrophils, is preferable to visualize the area and course of
infection.
In accordance with this idea, USPIO particles were evaluated in
recent years as inflammation specific contrast agents [5,10,17]. It
was shown, that ironoxide nanoparticles accumulate at the abscess
wall of S. aureus induced thigh muscle abscesses [5]. Histological
staining of imaged muscles demonstrated intracellular deposits of
ironoxide in macrophages. But even though USPIO particles
accumulated very strongly during chronic phase of inflammation,
and thereby lead to clear identification and localization of the
abscess area, their application during acute phase resulted only in
weak accumulation avoiding the determination of the abscess area
[10]. Furthermore, the application of ironoxide nanoparticles is
limited by the fact that they are usually detected by their local
signal extinction. For these reasons, it is difficult to unequivocally
determine accumulated ironoxide nanoparticles in tissues, which
appear dark on MR images or in neighborhood of other signal
distorting structures.
Perfluorocarbon (PFC) nanoparticles circumvent this problem
by delivering unambiguous signals in vivo due to the low natural
abundance of
19F [12]. As it has been demonstrated that they are
phagocytosed by the monocyte/macrophage system and to a
lower extend by granulocytes [15,16], the idea of this study was to
Figure 1. Representative MR Images of acute soft-tissue infection. A, B) Mouse received PFC at day 2 post infection. Images were recorded
24 h after administration. C, D) Mouse received CLIO at day 2 post infection and was imaged 24 h after administration. A) Transverse T2 map of PFC
group mouse shows hyperintensity within infected muscle (arrow). B)
19F-SSFP CSI overlay on
1H-TSE image of PFC treated mouse shows strong
accumulation of PFC at the rim of abscess area. C) Transverse T2 map of CLIO group mouse shows hyper-intense area diffusely circumscribed by dark
spots (arrow). D) T2* weighted image shows diffusely distributed susceptibility effects in the infected muscle (arrow). (Co: Control tube filled with PFC
dilution, R: right side, L: left side of the imaged mouse).
doi:10.1371/journal.pone.0018246.g001
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sites by MRI.
We administered PFC nanoparticles during acute or chronic
phase of inflammationand compared their accumulationpatternby
MRI with that of ironoxide particles (CLIO). CLIO group mice
showed accumulation of ironoxide in acute and chronic phase. The
accumulation in acute phase was diffuse and failed to define the
abscess area (Fig. 1D). In contrast, CLIO accumulated in chronic
phase at the rim of the edema pattern, defined by higher T2 values,
and formed a hollow sphere. PFC administration at acute phase
(Fig. 1B) led to a partially open hollow sphere around the edema
pattern and allowed the distinction of abscess area and surrounding
muscle tissue. Furthermore, PFC accumulated in chronic phase of
infection like CLIO characterized by forming a closed hollow
sphere around the edema pattern. Clearly, PFC accumulation was
easier to identify than ironoxide owing to their background-free
visualization. However, we cannot exclude the possibility that PFC
accumulated stronger than CLIO nanoparticles during acute phase.
The time course evaluation of PFC accumulation after administra-
tion during acute phase illustrated the stability of
19F signal around
the abscess area at least until d9 p.i.. Taken together, PFC is able to
target and visualize abscess formation in a S. aureus thigh abscess
model in both acute and chronic phase of infection, whereas CLIO
can only visualize the abscess area in chronic phase but fails to
define the abscess area in acute phase.
Histologic examination of imaged muscles revealed neutrophils
and some macrophages in the area where CLIO and PFC
accumulation has been detected by MRI in acute phase. Iron-
specific staining shows a few intracellular iron deposits in
macrophages and granulocytes. At chronic phase, iron-loaded
macrophages, lymphocytes and some granulocytes could be
detected. These data are in accordance to previous reports on
accumulation of ironoxide around soft-tissue abscesses [5,10].
Unfortunately, we could not visualize PFC accumulation by
histology as to our best knowledge there is no method available to
stain PFC nanoparticles in histological preparations. Importantly,
Figure 2. Representative MR Images of chronic soft-tissue infection. A, B) Mouse received PFC at day 8 post infection. Images were recorded
24 h after administration. C, D) Mouse received CLIO at day 8 post infection and was imaged 24 h after administration. A) Transverse T2 map of PFC
group mouse shows large hyper-intensity area within infected muscle (arrow). B)
19F-SSFP CSI overlay on
1H-TSE image of PFC group mouse shows
strong accumulation of PFC at the rim of abscess area. C) Transverse T2 map of CLIO group mouse shows hyper-intense area circumscribed by a dark
rim (arrows). D) T2* weighted image shows strong susceptibility effects around the infected muscle in a hollow sphere pattern (arrows (Co: Control
tube filled with PFC dilution, R: right side, L: left side of the imaged mouse).
doi:10.1371/journal.pone.0018246.g002
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ischemia demonstrated uptake of PFCs by phagocytic immune
cells [15,16]. Furthermore, the accumulation pattern of PFCs in
our infection model is congruent with CLIO accumulation around
the abscess. Finally, the validity of our method was further
confirmed by the fact that we could never visualize accumulation
of
19F in control thigh muscles, which were treated with
sodiumchlorid-solution. All these observations strongly suggest
accumulation of
19F signal at the abscess wall owing to the uptake
of PFCs by phagocytic immune cells and their subsequent
migration to the site of infection.
In conclusion, we have demonstrated that PFC nanoemulsions
accumulated in the shape of a hollow sphere at the abscess of a S.
aureus murine thigh infection model in both acute and chronic
phase of infection. The detected signal arises exclusively from the
nanoparticles due to the low biological abundance of
19F and the
localization of the signal could be correlated on an anatomical
1H-
MR image, what in turn enables the distinction of abscess area and
surrounding tissue. The new contrast media based MRI modality
presented here can be used to visualize inflammation, but may be
furthermore interesting to be applied to investigate host-pathogen
interaction, the efficacy of anti-microbial therapy, and the course
of infections in vivo non-invasively with high spatial resolution.
Materials and Methods
Ethic statement
All animal experiments were approved by the government of
Lower Franconia (54-2531.01-42/06) and were performed
according to the German animal protection law. All animals were
kept in cages under standardized lighting conditions and had ad
libitum access to food and water.
Figure 3. Representative MR-slice series showing the hollow sphere formed by PFC at acute phase. The depicted mouse received PFC at
day 2 after start of infection. Images were recorded 24 h after administration.
19F-SSFP CSI overlay on
1H-TSE image of PFC group mouse shows
strong accumulation of PFC at the rim of the abscess area.(Slice Thickness: 1 mm, FOV 25625 mm
2, Co: Control tube filled with PFC dilution, R: right
side, L: left side of the imaged mouse).
doi:10.1371/journal.pone.0018246.g003
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To evaluate the capability of PFC as contrast media to visualize
sites of infection, we choose a murine thigh infection model of S.
aureus because of the localized and bulky abscesses generated by
this model [18]. 16 female Balb/C mice (18–22 g, Charles-River,
Germany) were used for this study. While the animals received
inhalation anesthesia (1,5% isoflurane in O2), 50 ml of bacterial
suspension (1610
8 cfu per infection dose) in 0,9% NaCl-solution
was inoculated into the left thigh muscle. To visualize unspecific
contrast agent accumulation, 50 ml of sterile 0,9% NaCl-solution
was injected into the right thigh muscle. Bacterial suspension was
prepared by overnight incubation of Staphylococcus aureus Xen 29
(Xenogen, USA) in liquid B-medium. The bacteria were washed,
resuspended in 0,9% NaCl-solution and diluted to a final
concentration of 2610
9 colony-forming units per milliliter. The
infection dose was measured by optical density and checked by
plating dilutions on agar plates.
The mice were then assigned to one of five groups. Two groups
of 5 animals each received perfluorocarbon nanoemulsion at acute
or chronic phase of infection, whereas the two other groups of 3
animals each received CLIO nanoparticles. To evaluate accumu-
lation of contrast agent during acute phase, PFC or CLIO was
administered intravenously at day 2 post infection. The chronic
phase accumulation was investigated by administration of PFC or
CLIO at day 8 post infection. In each case, the mice were imaged
24 h after administration by MRI. The animals were sacrificed
within 3 hours after imaging by administration of inhalable pure
CO2.
To visualize the accumulation of PFC in time-course, we
administrated PFC 48h p.i. and imaged the
19F content at the
Figure 4. Representative MR-slice series showing the hollow sphere formed by PFC at chronic phase. The depicted mouse received PFC
at day 8 post infection. Images were recorded 24 h after administration.
19F-SSFP CSI overlay on
1H-TSE image of PFC group mouse shows strong
accumulation of PFC at the rim of abscess area. (Slice Thickness: 1 mm, FOV 25625 mm
2, Co: Control tube filled with PFC dilution, R: right side, L: left
side of the imaged mouse).
doi:10.1371/journal.pone.0018246.g004
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imaged at several time points between d3 and d9 p.i..
Histology
The infected thigh muscle was prepared anatomically, removed
and fixed in 10% neutral buffered formalin solution (Sigma-
Aldrich, Germany). The pathologic specimen were then embed-
ded in paraffin blocks according to standard procedures and cut to
2 mm thick transversal slices. Sections were stained with haema-
toxylin-eosin to characterize soft-tissue infection and with Berlin
blue staining to visualize iron content. The histologic findings were
evaluated by a pathologist (S. K.) and compared to MR images.
Contrast agents
The home-built dextran coated CLIO particles had a diameter of
30 nm while the core diameter was around 2–3 nm (Department of
Inorganic Chemistry, University of Wu ¨rzburg). It was emulgated in
phosphate buffered saline (6.8%o m/m) for injection. 16,8 mg Fe/kg
bodyweight were injected intravenously into the CLIO group mice.
The
19F nanoemulsion core compound was perflourocarbon
with a mean droplet diameter of approximately 145 nm. The 20%
v/v emulsion (VS1000H, Celsense, Inc., Pittsburgh, PA, USA) was
for direct intravenous injection. 100 ml of this emulsion was
administered intravenously into PFC group mice.
MRI measurements
Measurements were performed on a 7 Tesla Bruker Biospec
System (Bruker BioSpin GmbH, Reinstetten, Germany) at room
temperature with an adjustable double resonant (
1H and
19F)
home-built birdcage. The animals received inhalation anesthesia
(1% isoflurane) during measurement and were placed in a home-
built measurement container due to safety regulations.
Figure 5 Representative MR-slice series showing the time course of PFC accumulation following administration at acute phase.
Mouse received PFC at day 2 p.i. and was imaged every 48 h beginning at d3 p.i.. The upper row of images shows T2 weighted MR-slices, the lower
row the corresponding
19F-SSFP CSI overlays on
1H-TSE images.
19F signal could be visualized in all measurements until d9 p.i. (end point).
doi:10.1371/journal.pone.0018246.g005
Figure 6. Histological appearance of acute soft-tissue infection. A, C) Mice received CLIO at day 2 post infection and were imaged 24 h after
administration. The muscle was recovered immediately after imaging. B) Mice received PFC at day 2 post infection. Images were recorded 24 h after
administration. The muscle was recovered immediately after imaging. A) HE-staining shows that infiltrate in CLIO group mice consists mainly of
granulocytes. C) Iron-specific staining demonstrates iron deposits in granulocytes and macrophages (iron appears blue). B) HE-staining of PFC group
mouse reveals strong immune cell infiltrate mainly consisting of granulocytes.
doi:10.1371/journal.pone.0018246.g006
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sequence (TEeff/TR: 13.4 ms/2500 ms; inter-echo time: 6.7 ms;
turbo factor: 4; FOV: 25625 mm
2; matrix: 2006200; slice
thickness (SI): 1 mm; 16 slices, NA: 2).
For T2-mapping images were acquired by a multi slice multi
spin echo (MSME) sequence (TE/TR: 6 ms/6000 ms; NE: 40;
FOV: 25625 mm; matrix: 1286128; slice thickness (SI): 1 mm; 10
slices interlaced, NA: 1). For T2* mapping 3D multi gradient echo
(MGE) scans (TE/TR: 2 ms/100 ms; inter echo time: 2.7 ms; NE:
16; FOV: 40625625 mm
3; matrix: 128680680; NA: 2) were
performed.
Afterwards the signal decay parameters were fitted pixel by
pixel using a T2/T2* maximum likelihood estimation based on the
Rice distribution [19].
Regarding
19F-MRI acquisition-weighted [20] 3D steady-state
free precession CSI (SSFP-CSI) sequences [21] were performed
with the same geometry as the
1H-TSE scans (Pulse shape:
hermite; Pulse bandwidth: 5400 Hz; TACQ/TR: 10.24 ms/
13.6 ms; FOV: 25625616 mm
3; spectral points: 512; acquired
resolution/time equivalent: - matrix: 4864868; - NA: 4). For
overlay-images the signal of the
19F peak was integrated and
afterwards the dataset was zero-filled to a matrix of 2006200616
pixels. Furthermore a threshold was applied to the
19F data and
afterwards underlayed with the
1H-TSE data. For each measure-
ment the threshold of the overlay image was adjusted individually.
The overall protocol time was less than three hours.
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the abscess rim of CLIO group mice. C) Iron-specific staining demonstrates iron deposits in granulocytes and macrophages (iron appears blue). B) HE-
staining of PFC group mice reveals macrophages and granulocytes in fibroblast-enriched granulation tissue similar to CLIO group mice.
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